Financhill
Buy
60

DFS Quote, Financials, Valuation and Earnings

Last price:
$162.18
Seasonality move :
6.19%
Day range:
$155.52 - $164.36
52-week range:
$119.31 - $205.76
Dividend yield:
1.73%
P/E ratio:
9.16x
P/S ratio:
2.27x
P/B ratio:
2.42x
Volume:
2.4M
Avg. volume:
2.4M
1-year change:
33.79%
Market cap:
$40.8B
Revenue:
$17.9B
EPS (TTM):
$17.71

DFS Analysts' Consensus Rating

The 14 analysts providing 12-month price projections for Discover Financial Services shares anticipate an average target of $210.38, ranging from a low estimate of $169.00 to a high estimate of $262.00. This average target implies a growth of 29.7% compared to the current stock price of $162.21.

Consensus Price Target

$210.38

Highest Price Target

$262.00

Lowest Price Target

$169.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 5 5

Hold 12 10 9

Sell 0 0 0
Consensus Hold Hold Hold

DFS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 20

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Buy
82
EXOD alert for Mar 20

Exodus Movement [EXOD] is up 35.1% over the past day.

Sell
50
SRPT alert for Mar 20

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock